News

This webinar provides an overview of Ontario’s implementation of fetal blood group genotyping, including the Fetal RHD Screen and the Alloimmunized Fetal Blood Group Genotyping test.

The Canadian Obstetric Survey System (CanOSS), in partnership with BORN, is launching on October 5 CanOSS Ontario, the first provincial pilot of a national initiative to understand severe maternal complications and turn what is learned into safer care.

New province-wide screening supports more personalized pregnancy care while reducing unnecessary interventions.

A research team from McMaster University, the University of Ottawa, BORN Ontario and the University of Toronto is conducting a survey to better understand pregnancy care professionals’ knowledge, attitudes, preferences and practices related to RSV prevention products.

Newborn Screening Ontario (NSO) and the CHEO Research Institute are conducting the INFANT Study to explore how genomic newborn screening could help identify rare genetic conditions earlier in life.

BORN Ontario Scientific Director Dr. Mark Walker has led an international team of experts in a new seminar published in The Lancet examining the latest evidence on pre-eclampsia.

Join BORN Ontario for a practical webinar on Prenatal Screening for Aneuploidy in Ontario, designed to help health-care providers stay up to date on current screening pathways, counselling guidance and available resources.

This webinar highlights the health AI research happening at BORN Ontario, from foundational methods to real-world applications in perinatal and child health.

Understanding your risk for preterm preeclampsia early in pregnancy can help guide your care. When recommended by a healthcare provider, low-dose aspirin when recommended, can help reduce risks and support safer outcomes for both parent and baby. Talk to your healthcare provider about getting screened.